Chronic Kidney Disease
Research activity is centred on chronic kidney disease, with a focus on slowing loss of kidney function and supporting care for people receiving standard treatment. The studies examine therapies aimed at reducing the decline in estimated glomerular filtration rate and addressing progression across advanced stages of kidney impairment.
- Slowing progression of CKD
- Preserving eGFR
- Standard-of-care kidney disease management
Active work spans multiple collaborating sites and includes ongoing recruitment across several countries, reflecting a strong interest in treatment options for kidney disease.
Cardiovascular Disease in Advanced Kidney Disease
The sponsor also investigates cardiovascular outcomes in people with advanced chronic kidney disease and dialysis-dependent kidney failure. This area includes prevention of major heart and blood vessel disease events in populations with elevated cardiovascular risk.
- Cardiovascular death prevention
- Myocardial infarction and stroke risk reduction
- Peripheral arterial disease outcomes
These studies link nephrology and cardiology, with particular attention to people whose kidney disease is complicated by high vascular risk.
Therapeutic Innovation in Kidney and Vascular Medicine
Clinical research includes evaluation of new treatment approaches and combinations intended to improve outcomes in kidney disease and related cardiovascular disease. The therapeutic landscape includes agents designed to modify disease progression and reduce major vascular events in patients with advanced renal impairment.
- Investigational kidney disease therapies
- Combination treatment strategies
- Antithrombotic approaches in high-risk patients
Research activity is distributed across a broad international network of sites, supporting work in both renal medicine and vascular protection.
